Voltar
Revisão Acesso aberto Revisado por pares
BIBTEX RIS

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes

2020; American Medical Association; Volume: 6; Issue: 2 Linguagem: Inglês

10.1001/jamacardio.2020.4511

ISSN

2380-6591

Autores

Darren K. McGuire, Weichung Shih, Francesco Cosentino, B Charbonnel, David Z.I. Cherney, Samuel Dagogo‐Jack, Richard E. Pratley, Michelle Greenberg, Shuai Wang, Susan Huyck, Ira Gantz, Steven G. Terra, Urszula Masiukiewicz, Christopher P. Cannon,

Tópico(s)

Diabetes Management and Research

Resumo

Sodium-glucose cotransporter 2 (SGLT2) inhibitors favorably affect cardiovascular (CV) and kidney outcomes; however, the consistency of outcomes across the class remains uncertain.

Referência(s)